Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

Clinical trial NCT04586543 · UNKNOWN

Trial details

NCT number: NCT04586543
Sponsor: László Mangel
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer Adenocarcinoma of the Prostate

Start date: 2020-05-18
Primary completion: 2025-02-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.